1-20 of 39
Authors: Maciej Lesniak
Sort by
Journal Article
IMMU-54. THERAPEUTIC TARGETING OF STING IN MENINGIOMAS
Mark Youngblood and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii164, https://doi.org/10.1093/neuonc/noae165.0646
Published: 11 November 2024
Journal Article
IMMU-25. B-CELL BASED THERAPY (BVAX) PRODUCES ANTIBODIES TO SUPPRESS GLIOBLASTOMA TUMOR MIGRATION AND INVASION
Joshua Katz and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii157–viii158, https://doi.org/10.1093/neuonc/noae165.0618
Published: 11 November 2024
Journal Article
PATH-59. HISTOLOGIC CORRELATES FOR MOLECULAR FEATURES IN MENINGIOMAS
Harrshavasan Congivaram and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii192, https://doi.org/10.1093/neuonc/noae165.0758
Published: 11 November 2024
Journal Article
CNSC-45. EXTRINSIC ELECTRICAL MODULATION IMPACTS GLIOBLASTOMA TUMOR GROWTH BY DISRUPTING ITS INTERCELLULAR COMMUNICATION
Irina Palacin Aliana and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii51, https://doi.org/10.1093/neuonc/noae165.0201
Published: 11 November 2024
Journal Article
RADT-43. LONG TERM OUTCOMES OF PEDIATRIC AND ADULT CENTRAL NEUROCYTOMA—THE ROLE OF SALVAGE RADIOTHERAPY AND CONSERVATIVE MANAGEMENT
Yufan Yang and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v58, https://doi.org/10.1093/neuonc/noad179.0232
Published: 10 November 2023
Journal Article
IMMU-06. THE ROLE OF BRAIN TUMOR MICROENVIRONMENT ON T CELL TELOMERE SHORTENING
Gustavo Ignacio Vazquez Cervantes and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v142, https://doi.org/10.1093/neuonc/noad179.0538
Published: 10 November 2023
Journal Article
IMMU-43. IN-DEPTH SINGLE-CELL ANALYSIS OF THE IMMUNE LANDSCAPE IN CHORDOMAS REVEALS T-CELL EXHAUSTION AND INFORMS RATIONAL IMMUNOTHERAPEUTIC INTERVENTION
Victor Arrieta and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v152, https://doi.org/10.1093/neuonc/noad179.0575
Published: 10 November 2023
Journal Article
EXTH-52. HARNESSING A B CELL THERAPY TO PROMOTE ANTI-GLIOBLASTOMA HUMORAL RESPONSE
Brandyn Castro and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii220–vii221, https://doi.org/10.1093/neuonc/noac209.850
Published: 14 November 2022
Journal Article
TMIC-42. LEVERAGING B CELL IMMUNITY TO PROMOTE IMMUNOTHERAPY IN GLIOBLASTOMA
David Hou and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii280, https://doi.org/10.1093/neuonc/noac209.1086
Published: 14 November 2022
Journal Article
TMIC-78. CIRCADIAN REGULATOR CLOCK DRIVES IMMUNOSUPPRESSION IN GLIOBLASTOMA
Wenjing Xuan and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii289, https://doi.org/10.1093/neuonc/noac209.1121
Published: 14 November 2022
Journal Article
TMET-14. TUMOR-ASSOCIATED MYELOID CELL-DERIVED CREATINE PROMOTES GLIOBLASTOMA GROWTH IN HYPOXIC NICHES AND PSEUDOPALISADING TUMOR REGIONS
Andrew Zolp and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii264, https://doi.org/10.1093/neuonc/noac209.1019
Published: 14 November 2022
Journal Article
IMMU-29. B-CELL-BASED VACCINE PRODUCES GLIOBLASTOMA-REACTIVE ANTIBODIES THAT CONTRIBUTE TO TUMOR CLEARANCE
Brandyn Castro and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi98, https://doi.org/10.1093/neuonc/noab196.388
Published: 12 November 2021
Journal Article
CTIM-12. A PHASE 1 TRIAL OF IMMUNORADIOTHERAPY WITH THE IDO ENZYME INHIBITOR (BMS-986205) AND NIVOLUMAB IN PATIENTS WITH NEWLY DIAGNOSED MGMT PROMOTER UNMETHYLATED IDHwt GLIOBLASTOMA
Rimas Lukas and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi51–vi52, https://doi.org/10.1093/neuonc/noab196.204
Published: 12 November 2021
Journal Article
BIOM-32. ENDOPLASMIC RETICULUM PROTEIN SSR3 DETERMINES AND PREDICTS RESPONSE TO PACLITAXEL IN BREAST CANCER AND GLIOBLASTOMA
Crismita Dmello and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi17–vi18, https://doi.org/10.1093/neuonc/noab196.063
Published: 12 November 2021
Journal Article
EXTH-29. DUAL TGFB AND PD1 BLOCKADE PROMOTES GERMINAL-CENTER B-CELL IMMUNE RESPONSES AGAINST GLIOBLASTOMA
Mark Dapash and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi169, https://doi.org/10.1093/neuonc/noab196.668
Published: 12 November 2021
Journal Article
TAMI-25. UPREGULATION OF CREATINE METABOLISM BY MYELOID CELLS RESULTS IN GLIOBLASTOMA PROGRESSION
Aida Rashidi and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi203, https://doi.org/10.1093/neuonc/noab196.809
Published: 12 November 2021
Journal Article
IMMU-36. B CELL-VACCINE ELICITS LONG TERM IMMUNITY AGAINST GLIOBLASTOMA VIA ACTIVATION AND DIFFERENTIATION OF TUMOR-SPECIFIC CD8+ MEMORY T CELLS
David Hou and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi100, https://doi.org/10.1093/neuonc/noab196.395
Published: 12 November 2021
Journal Article
EXTH-43. GENERATION OF A B-CELL-BASED VACCINE FOR THE TREATMENT OF GLIOBLASTOMA
Catalina Lee Chang and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii96, https://doi.org/10.1093/neuonc/noaa215.397
Published: 09 November 2020
Journal Article
QOLP-11. QUALITY OF LIFE IN HIGH-GRADE GLIOMA PATIENTS ON A PHASE I VIROTHERAPY STUDY
Lauren Kloeppinger and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi216, https://doi.org/10.1093/neuonc/noy148.897
Published: 05 November 2018
Journal Article
EXTH-32. TRANSGENIC EXPRESSION OF IL15 IMPROVES THE EFFICACY OF CAR T CELLS IN AN IMMUNE COMPETENT GLIOBLASTOMA MODEL
Katarzyna Pituch and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi92, https://doi.org/10.1093/neuonc/noy148.381
Published: 05 November 2018
Advertisement
Advertisement